Authored By: Sarah
11 Jul 2024

 Electrophysiology Market Size to grow by USD 6.09 billion between 2024-2028

According to a research report “ Electrophysiology Market” by Product (Lab devices, Ablation catheters, Diagnostic catheters, Access devices) End-user (Hospitals and cardiac centers, ASCs) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 6.09 billion, at a CAGR of  10.71% during the forecast period. Atrial fibrillation (AFib) is a prevalent arrhythmia, with over 886,000 new diagnoses annually in Europe. By 2030, the European population with AFib is projected to surge by up to 70%, making it the region with the highest number of patients by 2050. In the US, AFib affected approximately 2.7-6.1 million people in 2012, with estimates suggesting a rise to 12.1 million by 2030. In Australia, the number of AFib patients aged above 55 years was 328,562 in June 2014, expected to exceed 600,000 by 2034. The global burden of AFib continues to grow, necessitating significant investments in electrophysiology technologies and treatments.

Browse market data tables, figures, and in-depth TOC on “Electrophysiology Market” by Product (Lab devices, Ablation catheters, Diagnostic catheters, Access devices) End-user (Hospitals and cardiac centers, ASCs) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample


By Product, the Lab devices segment is projected to dominate the market size in 2024

In the healthcare industry, Electrophysiology (EP) studies serve a pivotal function in the identification and treatment of cardiac arrhythmias within hospitals and specialized cardiac centers. The EP procedure commences with a comprehensive patient assessment, encompassing a physical examination, medical history review, and obtaining informed consent. Prior to the procedure, patients are instructed to fast. Utilizing advanced technologies, such as real-time fluoroscopy imaging and 3D mapping systems, electrophysiologists navigate catheters, outfitted with electrodes, with precision through blood vessels and into the heart. These catheters facilitate the diagnosis of irregular heart rhythms by stimulating the heart and recording its electrical activity upon placement. To pinpoint the origin of arrhythmias, electrophysiologists meticulously create and employ specific catheters.

By End-user, Hospitals and cardiac centers  segment is expected to hold the largest market size for the year 2024

An electrophysiology laboratory is a specialized healthcare facility outfitted with advanced equipment for diagnosing and treating cardiovascular conditions, including arrhythmia, fibrillation, congestive heart failure, and stroke. These state-of-the-art lab devices enable electrophysiologists to assess the electrical activity of the heart and provide immediate treatment for irregular heartbeats. Irregular heartbeats can potentially lead to complications such as heart failure and stroke. Three primary procedures executed in electrophysiology labs are cardiac mapping, which delineates the movement of electrical impulses within the heart muscle, enabling electrophysiologists to pinpoint the origin of arrhythmias, and ablation therapy, which utilizes heat or cold energy to correct abnormal heart rhythms, and cardioversion, which employs electrical shocks to restore a normal heart rhythm.

North America is forecasted to hold the largest market size by region in 2024

The North American electrophysiology market is experiencing significant growth, driven by increased public awareness of cardiovascular diseases and the incorporation of electrophysiology products into manufacturers' offerings. Notably, organizations such as the American Heart Association (AHA) spearhead campaigns to promote heart health awareness, including designating February as American Heart Month. This annual event, recognized by the federal government, provides a substantial platform for electrophysiology companies to showcase their brands to millions of potential customers. Major players in the sector, including Abbott Laboratories and Boston Scientific Corp., are capitalizing on this opportunity to expand their market presence.

The Electrophysiology Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • Acutus Medical Inc.
  • APN Health LLC
  • Asahi Kasei Corp.
  • Boston Scientific Corp.
  • CathRx Pty Ltd.
  • EP Solutions SA
  • EPMap System GmbH
  • GE Healthcare Technologies Inc.
  • Imricor Medical Systems Inc.
  • Japan Lifeline Co. Ltd.
  • Johnson and Johnson
  • Koninklijke Philips N.V.
  • Medtronic Plc
  • Merit Medical Systems Inc.
  • MicroPort Scientific Corp.
  • Siemens AG
  • Stereotaxis Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Electrophysiology (EP) market is experiencing significant growth due to the increasing prevalence of cardiovascular diseases, such as atrial fibrillation and arrhythmias. Hospitals are adopting next-gen devices, including AI-powered mapping systems, digital cloud technology, and telemedicine, to improve patient outcomes and streamline workflows. Advanced electrophysiology devices, such as 3D mapping systems, radio frequency generators, and ablation catheters, enable minimally invasive procedures and surgical interventions for treating abnormal heart rhythms. EP market devices include access devices, such as wire electrodes and catheters, which facilitate the delivery of therapeutic energy to the heart. Reimbursement policies are evolving to support the adoption of these advanced technologies, driving demand for EP devices. The integration of digital health solutions, such as telemedicine, is also transforming the EP market by expanding access to care and improving patient engagement. Overall, the EP market is poised for continued growth, driven by the need for more effective and efficient treatments for cardiovascular diseases. Buying behavior in the EP market is influenced by factors such as clinical outcomes, cost-effectiveness, and ease of use. As technology advances and reimbursement policies evolve, healthcare providers are increasingly turning to EP devices to improve patient care and reduce the burden of cardiovascular diseases.

Market Research Overview

Electrophysiology, a subspecialty of neurology and cardiology, focuses on diagnosing and treating abnormal heart rhythms, such as atrial fibrillation (AF), atrial flutter, and cardiac arrhythmias. The global Electrophysiology (EP) market is witnessing significant growth due to the increasing prevalence of chronic diseases like diabetes and high blood pressure, leading to an increased geriatric population with complex cardiovascular diseases. Advanced EP devices, such as AI-powered mapping systems, next-gen EP diagnostic catheters, EP laboratory devices, and EP ablation catheters, are driving market growth. Reimbursement policies, digital health, telemedicine, and digital cloud technology are transforming EP laboratories, enabling remote monitoring and minimally invasive procedures. Hospitals & cardiac centers, ambulatory surgery centers, and specialized healthcare workers, including technicians and nurses, require hands-on training and mentoring programs to address labor shortages. Expensive equipment, such as radiofrequency generators, 3D mapping systems, and ablation catheters, require capital investment and medical device licensing, with regulatory support ensuring patient safety and optimal patient outcomes. Technological development in imaging modalities, ablation catheters, and electrophysiological devices is leading to advanced ablation treatments and surgical interventions, improving medical care for patients with complex cardiovascular diseases. The EP market's buying behavior is influenced by healthcare spending, economies, and laws, with a focus on minimally invasive procedures and patient-centric care. Overall, the EP market is expected to continue growing, driven by technological advancements and the increasing demand for specialized healthcare providers to treat complex cardiovascular diseases.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!